Pfizer fined record £84.2m for overcharging NHS
7 December 2016
- From the section Business
Drugs giant Pfizer has been fined a record £84.2m by the UK’s competition watchdog for overcharging the NHS for an anti-epilepsy drug.
The Competition and Markets Authority (CMA) also fined distributor Flynn Pharma £5.2m for the 2,600% price increase for the drug in 2012.
NHS spending on the capsules rose from £2m a year in 2012 to about £50m in 2013.
UK prices for the drug were many times higher than in Europe, the CMA said.
This post was written by FSB News